A paracrine component of salient symptoms of depression in Cushing's of diencephalic origin, and in perimenstrual syndromes: A hypothesis

Medical Hypotheses

Volumn 66, Issue 5, 2006, Pages 936-938

  Dubrovsky, B ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; ESTROGEN; NEUROSTEROID;

ARTICLE; BIOSYNTHESIS; CUSHING SYNDROME; DEPRESSION; ESTROGEN BLOOD LEVEL; HORMONE ACTION; HORMONE SYNTHESIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MENSTRUAL CYCLE; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; STEROIDOGENESIS; SYMPTOM;

ADRENOCORTICOTROPIC HORMONE; CUSHING SYNDROME; DEPRESSION; DIENCEPHALON; ESTROGENS; FEMALE; HUMANS; HYPOTHALAMIC DISEASES; MENSTRUATION DISTURBANCES; MODELS, BIOLOGICAL; PARACRINE COMMUNICATION;

EID: 32144441724     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.11.034     Document Type: Article

References (19)

1. H. Cushing Psychiatric disturbances associated with disorders of the ductless glands Am J Insanity 69 1913 965 990
2. H. Cushing The basophil adenomas of the pituitary body and their clinical manifestations Bull John Hopkins Hospital 50 1932 137 195
3. B. Dubrovsky Adrenal steroids and the pathophysiology of a subset of depressive patients J Psych Neuroci 18 1993 1 13
4. S.I. Cohen Cushing's syndrome: a psychiatric study of 29 patients Br J Psychiatry 136 1980 120 124
5. W.F. Kelly, D.A. Checkley, Mashiter, and K. Bender Cushing's syndrome and depression: a prospective study of 26 patients Br J Psychiatry 142 1983 16 91
6. N.M. Starkman, D.E. Schteingart, and M.A. Schork Depressed mood and other psychiatric manifestations of Cushing's syndrome relationship to hormone levels Psychosom Med 43 1981 3 18
7. N.M. Starkman, and D.E. Schteingart Neuropsychiatric manifestations in Cushing's syndrome Arch Intern Med 141 1981 115 119
8. J.K. Belanoff, J. Rothschild, and F. Cassidy An open label trial of C-1073 (Mifepristone) for psychotic major depression Biol Psychiatry 52 2002 386 392
9. L.H. Price, R.T. Mahson, and C. McDougle Antiglucocorticoids as treatments for depression. Rationale use and therapeutic potentials CNS Drugs 5 1996 311 320
10. R.F. Haskell Diagnostic categorization of psychiatric disturbances in Cushing's syndrome Am J Psychiatry 142 1985 142 146
11. B.J. Carroll Psychoendocrine relations in affective disorders O.W. Hill Modern trends in psychosomatic medicine 1976 Butterworths London 129 133
12. B.O. Dubrovsky Steroids, neuractive steroids and neurosteroids in psychopathology Prog Neuropsychopharm Biol Psychiatry 29 2005 169 192
13. M. Greener Steroid actions get a rewrite Scientist 17 2003 32 34
14. J.M. Torres, E. Ruiz, and E. Ortega Effects of CRH and ACTH administration on plasma and brain neurosteroid levels Neurochem Res 26 5 2001 555 558
15. J.M. Torres, and E. Ortega DHEA, PREG and their sulphate derivatives on plasma and brain after CRH and ACTH administration Neurochem Res 28 8 2003 1187 1191
16. L.F. Agnati, K. Fuxe, C. Nicholoson, and E. Sykova Progress in brain research V125 2000 Elsevier Amsterdam
17. R. Maayan, B. Fisch, and M.A. Galsor Influence of 17β-estradiol on the synthesis of reduced neurosteroids in the brain (in vivo) and in glioma cells (in vitro): possible relevance to mental disorders in women Brain Res 1020 2004 167 172
18. B. Dubrovsky, J. Harris, and A. Tatarinov-Levin Effects of the active neurosteroid THDOC on long term potentiation. Implications for depression Prog Neuro-psychopharmacol Biol Psychiatry 28 2004 1029 1034
19. B. Dubrovsky Potential use of neurosteroids in the control of salient symptoms of depression and perimenstrual syndromes Drug Dev Ress 2005